Skip to main content
Erschienen in: Infection 6/2019

04.06.2019 | Original Paper

AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity

verfasst von: Eleonore Brumpt, Oleg Blagosklonov, Paul Calame, Solange Bresson-Hadni, Dominique Angèle Vuitton, Eric Delabrousse

Erschienen in: Infection | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To correlate the presence of calcifications in alveolar echinococcosis (AE) hepatic lesions to the metabolic activity in 18 fluorodeoxyglucose positron emission tomography combined with computed tomography (FDG-PET/CT).

Methods

Our institutional review board approved this study. 61 patients (29 women, 32 men, aged from 15 to 86 years) were included in the study. Images of FDG-PET/CT were interpreted by two independent nuclear medicine physicians. AE hepatic lesions were classified as AE lesions with or without hypermetabolic activity. The presence of calcifications was assessed on unenhanced CT scans by two independent radiologists blinded with regard to the metabolic activity of the AE hepatic lesions. Every single calcification the size of which was < 3 mm and non-measurable calcifications which were forming areas with a powdery appearance were considered as microcalcifications. All other types of calcifications were reported as macrocalcifications. Statistical analysis was performed and p value < 0.05 was considered as statistically significant.

Results

Microcalcifications and macrocalcifications were present at CT in 95% (58/61) AE hepatic lesions and 43% (26/61) AE hepatic lesions, respectively. Hypermetabolic activity was present at FDG-PET/CT in 93% (57/61) AE hepatic lesions. 98% (56/57) of the AE hepatic lesions presenting with hypermetabolic activity at FDG-PET/CT showed microcalcifications at CT (p = 0.01) when only 40% (23/57) showed macrocalcifications at CT (p = 0.3). 100% (23/23) of the AE hepatic lesions with hypermetabolic activity at FDG-PET/CT and macrocalcifications at CT showed also microcalcifications at CT.

Conclusions

Hypermetabolic activity of AE hepatic lesions at FDG-PET/CT is strongly correlated to the presence of microcalcifications at CT, independently of the presence of macrocalcifications.
Literatur
1.
Zurück zum Zitat Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, Vuitton DA. The Echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol. 2017;96:259–369.CrossRef Kern P, Menezes da Silva A, Akhan O, Müllhaupt B, Vizcaychipi KA, Budke C, Vuitton DA. The Echinococcoses: diagnosis, clinical management and burden of disease. Adv Parasitol. 2017;96:259–369.CrossRef
2.
Zurück zum Zitat Vuitton DA, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, Giraudoux P. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology. 2003;127(Suppl):S87–107.CrossRef Vuitton DA, Zhou H, Bresson-Hadni S, Wang Q, Piarroux M, Raoul F, Giraudoux P. Epidemiology of alveolar echinococcosis with particular reference to China and Europe. Parasitology. 2003;127(Suppl):S87–107.CrossRef
3.
Zurück zum Zitat Brunetti E, Kern P, Vuitton DA. Writing Panel for the WHO-IWGE Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.CrossRef Brunetti E, Kern P, Vuitton DA. Writing Panel for the WHO-IWGE Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114(1):1–16.CrossRef
4.
Zurück zum Zitat Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, Fischer DR, Müllhaupt B. Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable Alveolar Echinococcosis with negative FDG-PET/CT and Anti-EmII/3-10 Serology. PLoS Negl Trop Dis. 2015;9(9):e0003964.CrossRef Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, Fischer DR, Müllhaupt B. Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable Alveolar Echinococcosis with negative FDG-PET/CT and Anti-EmII/3-10 Serology. PLoS Negl Trop Dis. 2015;9(9):e0003964.CrossRef
5.
Zurück zum Zitat Bardonnet K, Vuitton DA, Grenouillet F, Mantion GA, Delabrousse E, Blagosklonov O, Miguet JP, Bresson-Hadni S. 30-year course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient. Ann Clin Microbiol Antimicrob. 2013;2(12):1. https://doi.org/10.1186/1476-0711-12-1.CrossRef Bardonnet K, Vuitton DA, Grenouillet F, Mantion GA, Delabrousse E, Blagosklonov O, Miguet JP, Bresson-Hadni S. 30-year course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient. Ann Clin Microbiol Antimicrob. 2013;2(12):1. https://​doi.​org/​10.​1186/​1476-0711-12-1.CrossRef
6.
Zurück zum Zitat Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Gillet M, Ito A, Mantion GA, Vuitton DA. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl. 2011;17(7):855–65.CrossRef Bresson-Hadni S, Blagosklonov O, Knapp J, Grenouillet F, Sako Y, Delabrousse E, Brientini MP, Richou C, Minello A, Antonino AT, Gillet M, Ito A, Mantion GA, Vuitton DA. Should possible recurrence of disease contraindicate liver transplantation in patients with end-stage alveolar echinococcosis? A 20-year follow-up study. Liver Transpl. 2011;17(7):855–65.CrossRef
7.
Zurück zum Zitat Liu W, Delabrousse É, Blagosklonov O, Wang J, Zeng H, Jiang Y, Wang J, Qin Y, Vuitton DA, Wen H. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite. 2014;21:74.CrossRef Liu W, Delabrousse É, Blagosklonov O, Wang J, Zeng H, Jiang Y, Wang J, Qin Y, Vuitton DA, Wen H. Innovation in hepatic alveolar echinococcosis imaging: best use of old tools, and necessary evaluation of new ones. Parasite. 2014;21:74.CrossRef
8.
Zurück zum Zitat Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, MacPherson CN, Craig PS. Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg. 2002;66(1):23–9.CrossRef Bartholomot G, Vuitton DA, Harraga S, Shi DZ, Giraudoux P, Barnish G, Wang YH, MacPherson CN, Craig PS. Combined ultrasound and serologic screening for hepatic alveolar echinococcosis in central China. Am J Trop Med Hyg. 2002;66(1):23–9.CrossRef
9.
Zurück zum Zitat Kantarci M, Bayraktutan U, Karabulut N, Aydinli B, Ogul H, Yuce I, Calik M, Eren S, Atamanalp SS, Oto A. Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics. 2012;32(7):2053–70.CrossRef Kantarci M, Bayraktutan U, Karabulut N, Aydinli B, Ogul H, Yuce I, Calik M, Eren S, Atamanalp SS, Oto A. Alveolar echinococcosis: spectrum of findings at cross-sectional imaging. Radiographics. 2012;32(7):2053–70.CrossRef
10.
Zurück zum Zitat Reuter S, Kratzer W, Kurz S, Wellinghausen N, Kern P. Chemotherapy of alveolar echinococcosis with benzimidazoles. A prospective long-term study. Med Klin (Munich). 1998;93(8):463–7.CrossRef Reuter S, Kratzer W, Kurz S, Wellinghausen N, Kern P. Chemotherapy of alveolar echinococcosis with benzimidazoles. A prospective long-term study. Med Klin (Munich). 1998;93(8):463–7.CrossRef
11.
Zurück zum Zitat Reuter S, Grüner B, Buck AK, Blumstein N, Kern P, Reske SN. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin. 2008;47(4):147–52.CrossRef Reuter S, Grüner B, Buck AK, Blumstein N, Kern P, Reske SN. Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET. Nuklearmedizin. 2008;47(4):147–52.CrossRef
12.
Zurück zum Zitat Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA, Bresson-Hadni S, Delabrousse E. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdom Imaging. 2015;40(1):56–63.CrossRef Azizi A, Blagosklonov O, Lounis A, Berthet L, Vuitton DA, Bresson-Hadni S, Delabrousse E. Alveolar echinococcosis: correlation between hepatic MRI findings and FDG-PET/CT metabolic activity. Abdom Imaging. 2015;40(1):56–63.CrossRef
13.
Zurück zum Zitat Pittella JE. Pathology of CNS parasitic infections. Handb Clin Neurol. 2013;114:65–88.CrossRef Pittella JE. Pathology of CNS parasitic infections. Handb Clin Neurol. 2013;114:65–88.CrossRef
14.
Zurück zum Zitat Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, Kull T, Barth TF, Kern P, Gruener B. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016;22(13):3621–31.CrossRef Graeter T, Kratzer W, Oeztuerk S, Haenle MM, Mason RA, Hillenbrand A, Kull T, Barth TF, Kern P, Gruener B. Proposal of a computed tomography classification for hepatic alveolar echinococcosis. World J Gastroenterol. 2016;22(13):3621–31.CrossRef
15.
Zurück zum Zitat Charbonnier A, Knapp J, Demonmerot F, Bresson-Hadni S, Raoul F, Grenouillet F, Millon L, Vuitton DA, Damy S. A new data management system for the French National Registry of human alveolar echinococcosis cases. Parasite. 2014;21:69.CrossRef Charbonnier A, Knapp J, Demonmerot F, Bresson-Hadni S, Raoul F, Grenouillet F, Millon L, Vuitton DA, Damy S. A new data management system for the French National Registry of human alveolar echinococcosis cases. Parasite. 2014;21:69.CrossRef
16.
Zurück zum Zitat Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013;54(3):358–63.CrossRef Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013;54(3):358–63.CrossRef
17.
Zurück zum Zitat Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg. 1987;36(3):576–85.CrossRef Rausch RL, Wilson JF, Schantz PM, McMahon BJ. Spontaneous death of Echinococcus multilocularis: cases diagnosed serologically (by Em2 ELISA) and clinical significance. Am J Trop Med Hyg. 1987;36(3):576–85.CrossRef
18.
Zurück zum Zitat Peng X, Li J, Wu X, Zhang S, Niu J, Chen X, Yao J, Sun H. Detection of Osteopontin in the pericyst of human hepatic Echinococcus granulosus. Acta Trop. 2006;100(3):163–71.CrossRef Peng X, Li J, Wu X, Zhang S, Niu J, Chen X, Yao J, Sun H. Detection of Osteopontin in the pericyst of human hepatic Echinococcus granulosus. Acta Trop. 2006;100(3):163–71.CrossRef
19.
Zurück zum Zitat O’Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol. 2000;81(6):373–90.CrossRef O’Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol. 2000;81(6):373–90.CrossRef
20.
Zurück zum Zitat Mueller J, Stojkovic M, Kauczor HU, Junghanss T, Weber TF. Performance of magnetic resonance susceptibility-weighted imaging for detection of calcifications in patients with hepatic echinococcosis. J Comput Assist Tomogr. 2018;42(2):211–5.PubMed Mueller J, Stojkovic M, Kauczor HU, Junghanss T, Weber TF. Performance of magnetic resonance susceptibility-weighted imaging for detection of calcifications in patients with hepatic echinococcosis. J Comput Assist Tomogr. 2018;42(2):211–5.PubMed
Metadaten
Titel
AE hepatic lesions: correlation between calcifications at CT and FDG-PET/CT metabolic activity
verfasst von
Eleonore Brumpt
Oleg Blagosklonov
Paul Calame
Solange Bresson-Hadni
Dominique Angèle Vuitton
Eric Delabrousse
Publikationsdatum
04.06.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2019
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01328-z

Weitere Artikel der Ausgabe 6/2019

Infection 6/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.